ClinicalTrials.Veeva

Find clinical trials for Adenocarcinoma in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Valencia, VC, ESP:

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

with HER2-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma who have progressed on or after a trastuzumab-containing regim...

Enrolling
Gastric Cancer, Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Drug: Ramucirumab
Drug: Paclitaxel

Phase 3

Daiichi Sankyo

Valencia, Spain and 156 other locations

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Valencia, Spain and 197 other locations

The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: oxaliplatin
Drug: capecitabine

Phase 3

Astellas
Astellas

Valencia, Spain and 164 other locations

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Enrolling
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Capecitabine
Drug: Fluorouracil

Phase 3

Arcus Biosciences
Arcus Biosciences

Valencia, Spain and 196 other locations

The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: gemcitabine
Drug: nab-paclitaxel

Phase 2

Astellas
Astellas

Castello de la plana, Spain and 182 other locations

This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...

Enrolling
Gastroesophageal Adenocarcinoma
Esophageal Adenocarcinoma
Drug: 5-Fluorouracil
Drug: Zanidatamab

Phase 3

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Zaragoza, Spain and 314 other locations

A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer

Enrolling
Pancreatic Adenocarcinoma
Metastatic
Genetic: VCN-01
Drug: Gemcitabine

Phase 2

Theriva Biologics

Valencia, Spain and 16 other locations

placebo plus chemotherapy as first-line (1L) therapy for locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma...

Active, not recruiting
Gastric, or Gastroesophageal Junction Adenocarcinoma
Drug: Oxaliplatin
Drug: Cisplatin

Phase 3

BeiGene
BeiGene

Valencia, Spain and 150 other locations

This is an open-label, parallel group, non-randomized, multicenter phase II study to evaluate the efficacy of spartalizumab (cohorts 1 and 2) and tis...

Enrolling
Pancreatic Adenocarcinoma
Prostate Adenocarcinoma
Drug: Tislelizumab
Drug: Spartalizumab

Phase 2

SOLTI

Valencia, Spain and 12 other locations

This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for whom previous trea...

Enrolling
Lung Neoplasms
Bladder Cancer
Drug: brigimadlin

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Valencia, Spain and 61 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems